NDLI: Regulatory polymorphisms underlying complex disease traits

Please wait, while we are loading the content...

A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity

Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor β but not the estrogen receptor α gene

New ABCC6 gene mutations in German pseudoxanthoma elasticum patients

Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin

Single nucleotide polymorphism map of five long-QT genes

Journal of Molecular Medicine : Volume 83, Issue 1, January 2005

Journal of Molecular Medicine : Volume 82

Journal of Molecular Medicine : Volume 81

Journal of Molecular Medicine : Volume 80

Journal of Molecular Medicine : Volume 79

Journal of Molecular Medicine : Volume 78

Journal of Molecular Medicine : Volume 77

Journal of Molecular Medicine : Volume 76

Journal of Molecular Medicine : Volume 75

Regulatory polymorphisms underlying complex disease traits

Content Provider	Springer Nature Link
Author	Knight, Julian C.
Copyright Year	2004
Abstract	There is growing evidence that genetic variation plays an important role in the determination of individual susceptibility to complex disease traits. In contrast to coding sequence polymorphisms, where the consequences of non-synonymous variation may be resolved at the level of the protein phenotype, defining specific functional regulatory polymorphisms has proved problematic. This has arisen for a number of reasons, including difficulties with fine mapping due to linkage disequilibrium, together with a paucity of experimental tools to resolve the effects of non-coding sequence variation on gene expression. Recent studies have shown that variation in gene expression is heritable and can be mapped as a quantitative trait. Allele-specific effects on gene expression appear relatively common, typically of modest magnitude and context specific. The role of regulatory polymorphisms in determining susceptibility to a number of complex disease traits is discussed, including variation at the VNTR of INS, encoding insulin, in type 1 diabetes and polymorphism of CTLA4, encoding cytotoxic T lymphocyte antigen, in autoimmune disease. Examples where regulatory polymorphisms have been found to play a role in mongenic traits such as factor VII deficiency are discussed, and contrasted with those polymorphisms associated with ischaemic heart disease at the same gene locus. Molecular mechanisms operating in an allele-specific manner at the level of transcription are illustrated, with examples including the role of Duffy binding protein in malaria. The difficulty of resolving specific functional regulatory variants arising from linkage disequilibrium is demonstrated using a number of examples including polymorphism of CCR5, encoding CC chemokine receptor 5, and HIV-1 infection. The importance of understanding haplotypic structure to the design and interpretation of functional assays of putative regulatory variation is highlighted, together with discussion of the strategic use of experimental tools to resolve regulatory polymorphisms at a transcriptional level. A number of examples are discussed including work on the TNF locus which demonstrate biological and experimental context specificity. Regulatory variation may also operate at other levels of control of gene expression and the modulation of splicing at PTPRC, encoding protein tyrosine phosphatase receptor-type C, and of translational efficiency at F12, encoding factor XII, are discussed.
Starting Page	97
Ending Page	109
Page Count	13
File Format	PDF
ISSN	09462716
Journal	Journal of Molecular Medicine
Volume Number	83
Issue Number	2
e-ISSN	14321440
Language	English
Publisher	Springer-Verlag
Publisher Date	2004-12-09
Publisher Place	Berlin/Heidelberg
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Gene expression Genetics Gene polymorphism Promoter Transcription
Content Type	Text
Resource Type	Article
Subject	Drug Discovery Molecular Medicine Genetics (clinical)

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Regulatory polymorphisms underlying complex disease traits.

Regulatory polymorphisms underlying complex disease traits

Genetic determinants of neuroglobin transcription

Paraoxonase gene polymorphisms, oxidative stress, and diseases

Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system

Apolipoprotein E gene promoter (–219G/T) polymorphism is associated with premature coronary heart disease

Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity

Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease

Ornithine decarboxylase gene expression in Castleman's disease

Regulatory polymorphisms underlying complex disease traits

Similar Documents

Regulatory polymorphisms underlying complex disease traits.

Regulatory polymorphisms underlying complex disease traits

Genetic determinants of neuroglobin transcription

Paraoxonase gene polymorphisms, oxidative stress, and diseases

Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter system

Apolipoprotein E gene promoter (–219G/T) polymorphism is associated with premature coronary heart disease

Functional impact of endotoxin receptor CD14 polymorphisms on transcriptional activity

Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease

Ornithine decarboxylase gene expression in Castleman's disease

Regulatory polymorphisms underlying complex disease traits